![Tracey Martin](https://profiles-cardiff.imgix.net/attachments/2505?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr Tracey Martin
(she/her)
- Available for postgraduate supervision
Teams and roles for Tracey Martin
Senior Lecturer in Cell and Tumour Biology, Director of Postgraduate Research
Overview
After a PhD in molecular Biology at Cardiff University, I began a Post-doctoral career at The University of Wales College of Medicine, investigating the role of Hepatocyte Growth Factor (HGF) on endothelia. This led to the opportunity to examine HGF and its antagonist NK4 in cancer. Since 1998, I have been involved in researching the role of tight junctions in cancer (during metastasis) and in endothelia (during angiogenesis). My research interests include investigating how tight junctions can be modulated to control cancer cell dissociation and invasion, together with a continued interest in angiogenic factors and their role in metastasis. I have a specific interest in brain metastasis and the role of tight junctions win the blood brain barrier. My team are actively reearching the underlysing mechanisms involved and possible therapeutic targets/new therapies.
Other roles:
- Director of School of Medicine Post Graduate Research
- Director of the School of Medicine International Winter and Summer Scholars Programmes
- Chair of the Division of Cancer and Genetics Equality, Diversity and Inclusion committee
- School of Medicine Wellbeing Champion
Publication
2026
- Cong, B. et al., 2026. MLN51 (Metastatic Lymph Node Gene 51)/CASC3 (Cancer Susceptibility Candidate Gene 3), A putative tumour suppressor in breast cancer, the clinical and therapeutic connections. Breast Cancer: Targets and Therapy 18
2025
- Ji, W. et al. 2025. Knockdown of claudin-8 (CLDN8) indicates a link between breast cancer cell sensitivity to chemotherapeutics and reveals a potential use of CLDN8 as a molecular diagnostic and target for therapy. International Journal of Molecular Sciences 26 (11) 5412. (10.3390/ijms26115412)
- Ji, W. et al. 2025. Tight junctional protein family, Claudins in cancer and cancer metastasis. Frontiers in Oncology 15 1596460. (10.3389/fonc.2025.1596460)
- O’Neill, N. S. et al. 2025. Correlation of GD2 biosynthesis enzymes with cancer stem cell markers in human breast cancer. Cancer Genomics & Proteomics 22 (2), pp.231-246. (10.21873/cgp.20498)
- Tong, J. et al. 2025. DRIM modulates Src activation and regulates angiogenic functions in vascular endothelial cells. Cell Biology International 49 (3), pp.277-287. (10.1002/cbin.12265)
- Wazir, U. et al., 2025. CD84 as a prognostic biomarker and therapeutic target in breast cancer: Interconnections with PDL1, CD74, and immune tolerance mechanisms. Cancer Genomics & Proteomics 22 (4), pp.557-563. (10.21873/cgp.20521)
- Yu, R. Y. , Jiang, W. G. and Martin, T. A. 2025. The WASP/WAVE protein family in breast cancer and their role in the metastatic cascade. Cancer Genomics & Proteomics 22 (2), pp.166-187. (10.21873/cgp.20495)
- Zhu, K. et al., 2025. Tumor exosomal miR-221-3p induces glycolysis through the LIFR/GLUT1 pathway to destroy the cerebral vascular endothelial cell barrier and promote breast cancer brain metastasis. Journal of Translational Medicine 23 (1) 1333. (10.1186/s12967-025-07372-8)
2024
- Li, A. X. et al., 2024. Cellular impacts of striatins and the STRIPAK complex and their roles in the development and metastasis in clinical cancers. Cancers 16 (1) 76. (10.3390/cancers16010076)
- Li, A. X. et al. 2024. Metastatic Lymph Node 64 (MLN64) expression in gastric cancer, the clinical and molecular implications in drug resistance. Cancer Genomics & Proteomics 21 (1), pp.30-40. (10.21873/cgp.20427)
- Zeng, J. et al. 2024. EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancer. Scientific Reports 14 (1) 30850. (10.1038/s41598-024-81485-w)
- Zhu, K. et al., 2024. Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-β/Smad signal pathway. Journal of Neuro-Oncology 170 , pp.331-345. (10.1007/s11060-024-04797-x)
2023
- Frugtniet, B. A. et al. 2023. nWASP inhibition increases wound healing via TrKb/PLCγ signalling. Biomolecules 13 (2) 379. (10.3390/biom13020379)
- Li, A. X. et al. 2023. Striatins and the STRIPAK complex partners in the clinical outcome of patients with breast cancer and responses to drug treatment. Chinese Journal of Cancer Research 35 , pp.365-385. (10.21147/j.issn.1000-9604.2023.04.04)
- Zhuang, X. et al. 2023. Claudin-10 in the blood brain barrier function of cerebral endothelial cells and transendothelial invasion of breast cancer cells. Anticancer Research 43 (9), pp.3923-3934. (10.21873/anticanres.16580)
- Zhuang, X. et al., 2023. Expression of Claudin-9 (CLDN9) in breast cancer, the clinical significance in connection with its subcoat anchorage proteins ZO-1 and ZO-3 and impact on drug resistance. Biomedicines 11 (12) 3136. (10.3390/biomedicines11123136)
2022
- Gao, H. et al., 2022. P-211 Claudin-16, its clinical and prognostic value in colorectal cancer. Annals of Oncology 33 , pp.S324-S324. (10.1016/j.annonc.2022.04.301)
- Sui, L. et al. 2022. P-282 Impact of death-associated protein-3 (DAP3) and DAP3 binding cell death enhancer 1 (DELE1) on drug sensitivity in colorectal cancer cells. Annals of Oncology 33 , pp.S347. (10.1016/j.annonc.2022.04.371)
- Sui, L. et al. 2022. Death associated protein-3 (DAP3) and DAP3 binding cell death enhancer-1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance. International Journal of Oncology 62 (1) 7. (10.3892/ijo.2022.5455)
- Telford, E. A. et al. 2022. Hepatitis A virus cellular receptor 1 (HAVcr-1) initiates prostate cancer progression in human cells via hepatocyte growth factor (HGF)-induced changes in junctional integrity. Biomolecules 12 (2) 338. (10.3390/biom12020338)
2021
- Gong, W. et al., 2021. Location, function and role of stromal cell-derived factors and possible implications in cancer. International Journal of Molecular Medicine 47 (2), pp.435-443. (10.3892/ijmm.2020.4811)
- Liu, C. et al. 2021. SIPA1 Is a modulator of HGF/MET induced tumour metastasis via the regulation of tight junction-based cell to cell barrier function. Cancers 13 (7) 1747. (10.3390/cancers13071747)
- Martin, T. A. et al. 2021. NUPR1 and its potential role in cancer and pathological conditions (Review). International Journal of Oncology 58 (5) 21. (10.3892/ijo.2021.5201)
- Xin, L. et al., 2021. SIKs suppress tumor function and regulate drug resistance in breast cancer. American Journal of Cancer Research 11 (7), pp.3537-3557.
2020
- Cong, Y. et al., 2020. Tim-3 promotes cell aggressiveness and paclitaxel resistance through the NF-κB /STAT3 signalling pathway in breast cancer cells. Chinese Journal of Cancer Research 32 (5), pp.564-579. (10.21147/j.issn.1000-9604.2020.05.02)
- Gong, W. et al., 2020. Influence of anaesthetics on the production of cancer cell motogens, stromal cell-derived factor-1 and hepatocyte growth factor by fibroblasts. Oncology Letters 21 (2) 140. (10.3892/ol.2020.12401)
- Liu, C. et al. 2020. The role of SIPA1 in the development of cancer and metastases (Review). Molecular and Clinical Oncology 13 (4) 32. (10.3892/mco.2020.2102)
- Wazir, U. et al., 2020. Stratification using hTERT and stem cell markers confers a good prognosis in invasive breast cancer. Cancer Genomics and Proteomics 17 (2), pp.169-174. (10.21873/cgp.20177)
- Zhao, Z. et al. 2020. Abstract P2-07-01: Kidins220 (kinase D interacting substrate 220) has a connection with neutrotrophic related factors, BDNF and NGF, in human breast cancer. Presented at: San Antonio Breast Cancer Symposium San Antonio, TX, United States 10-14 December 2019. Vol. 80.Vol. 4, Sup. , pp.P2-07-01. (10.1158/1538-7445.SABCS19-P2-07-01)
- Zhao, Z. et al. 2020. Abstract P3-01-18: Kinase D interacting substrate 220 (Kidins220) and disease progression of breast cancer, the role of heat shock protein90 (HSP90). Presented at: San Antonio Breast Cancer Symposium San Antonio, TX, United States 10-14 December 2019. Vol. 80.Vol. 4, Sup. American Association for Cancer Research. , pp.P3-01-18. (10.1158/1538-7445.SABCS19-P3-01-18)
2019
- Wazir, U. et al., 2019. Correlation of TERT and stem cell markers in the context of human breast cancer. Cancer Genomics and Proteomics 16 (2), pp.121-127. (10.21873/cgp.20117)
- Xu, Y. et al., 2019. BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis. European Review for Medical and Pharmacological Sciences 23 (12), pp.5093-5100. (10.26355/eurrev_201906_18173)
2018
- Jia, J. et al., 2018. Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways. International Journal of Molecular Medicine 41 (1), pp.275-283. (10.3892/ijmm.2017.3224)
2017
- Frugtniet, B. A. et al. 2017. Neural Wiskott-Aldrich syndrome protein (nWASP) is implicated in human lung cancer invasion. BMC Cancer 17 (1) 224. (10.1186/s12885-017-3219-3)
- Gu, Y. et al., 2017. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway. Oncotarget 8 (5), pp.7753-7765. (10.18632/oncotarget.13949)
- Ismail, A. F. et al., 2017. PAK5 mediates cell: cell adhesion integrity via interaction with E-cadherin in bladder cancer cells. Biochemical Journal 474 (8), pp.1333-1346. (10.1042/BCJ20160875)
- Telford, E. , Jiang, W. G. and Martin, T. A. 2017. HAVcR-1 involvement in cancer progression. Histology and Histopathology 32 , pp.121-128. (10.14670/HH-11-817)
- Xin, L. et al. 2017. The era of multigene panels comes? The clinical utility of Oncotype DX and MammaPrint. World Journal of Oncology 8 (2), pp.34-40. (10.14740/wjon1019w)
- Yang, X. et al., 2017. A novel NHERF1 mutation in human breast cancer and effects on malignant progression. Anticancer Research 37 (1), pp.67-73. (10.21873/anticanres.11290)
- Zhao, H. et al., 2017. The effect of aurora kinase inhibitor on adhesion and migration in human breast cancer cells and clinical implications. World Journal of Oncology 8 (5), pp.151-161. (10.14740/wjon1062w)
2016
- Jia, W. et al., 2016. Expression of the Epithelial-Mesenchymal-Transition (EMT) markers, Twist, Slug, Snail, E- and N-cadherins and the association with clinical and pathological features of human pituitary adenomas [Abstract]. European Journal of Cancer 51 (S3), pp.S592-S593. 2925. (10.1016/S0959-8049(15)30055-1)
- Liu, R. et al., 2016. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer. International Journal of Oncology 48 (6), pp.2488-2496. (10.3892/ijo.2016.3462)
- Martin, T. A. et al. 2016. Metastasis to bone in human cancer is associated with loss of occludin expression. Anticancer Research 36 (3), pp.1287-1294.
- Yang, X. et al., 2016. The impact of TIMM17A on aggressiveness of human breast cancer cells. Anticancer Research 36 (3), pp.1237-1241.
- Zhao, H. et al. 2016. The clinical implications of RSK1-3 in human breast cancer. Anticancer Research 36 (3), pp.1267-1274.
- Zhao, H. et al. 2016. Effect of junctional adhesion molecule-2 expression on cell growth, invasion and migration in human colorectal cancer. International Journal of Oncology 48 (3), pp.929-936. (10.3892/ijo.2016.3340)
- Zhao, H. et al. 2016. The role of JAM-B in cancer and cancer metastasis (Review). Oncology Reports 36 , pp.3-9. (10.3892/or.2016.4773)
2015
- Ali, A. Y. et al. 2015. Anti-metastatic and cytotoxic properties of frankincense and scented myrrh. Anticancer Research 35 (7), pp.4310-4311.
- Fang, X. , Jiang, W. G. and Martin, T. A. 2015. The role of claudin-5 in the cell-cell adhesion of human keratinocytes. Anticancer Research 35 (7), pp.4367.
- Frugtniet, B. , Jiang, W. G. and Martin, T. A. 2015. Investigating the effect of NWASP (Neural Wiskott-Aldrich Syndrome Protein) inhibitors on human lung cancer cell behaviour. Anticancer Research 35 (7), pp.4348-4349.
- Frugtniet, B. , Jiang, W. G. and Martin, T. A. 2015. Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis. Breast Cancer: Targets and Therapy 2015 (7), pp.99-109. (10.2147/BCTT.S59006)
- Jia, W. et al., 2015. Epithelial-mesenchymal transition (EMT) markers in human pituitary adenomas indicate a clinical course. Anticancer Research 35 (5), pp.2635-2643.
- Jia, W. et al., 2015. Expression of metastasis-associated gene-1 is associated with bone invasion and tumor stage in human pituitary adenomas. Cancer Genomics and Proteomics 12 (3), pp.113-118.
- Jia, W. et al., 2015. Association of mta-1 expression in pituitary tumours with bone invasion. Anticancer Research 35 (7), pp.4360.
- Jiang, W. G. et al. 2015. YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells. Journal of Translational Medicine 13 280. (10.1186/s12967-015-0639-1)
- Liu, R. et al., 2015. Metastasis suppressor 1 (MTSS1) expression in human ovarian cancer; the impact on cellular migration and metastasis [Abstract]. Anticancer Research 35 (7), pp.4342-4342.
- Liu, R. et al., 2015. Metastasis suppressor 1 expression in human ovarian cancer: the impact on cellular migration and metastasis. International Journal of Oncology 47 (4), pp.1429-1439. (10.3892/ijo.2015.3121)
- Martin, T. A. et al. 2015. Comparison of blood brain barrier endothelia reveals a differential expression of tight junction proteins [Abstract]. Anticancer Research 35 (7), pp.4357-4358.
- Martin, T. A. , Telford, E. and Jiang, W. G. 2015. HAVCR1 is a potential prognostic factor in human breast cancer. Anticancer Research 35 (7), pp.4327.
- Martin, T. A. and Tiang, W. G. 2015. The blood brain barrier and the prevention of metastatic disease. Anticancer Research 35 (7), pp.4298-4299.
- Men, W. et al., 2015. Expression of claudins in human clear cell renal cell carcinoma. Cancer Genomics and Proteomics 12 (1), pp.1-8.
- Owen, S. et al., 2015. An investigation of Amphiphysin II transcript expression in pituitary adenomas [Abstract]. European Journal of Cancer 51 (S3), pp.S580-S580. 2806. (10.1016/S0959-8049(15)30053-8)
- Owen, S. et al., 2015. The prostate Transglutaminase, TGase-4, is potentially linked to the junctional proteins at tight junctions of prostate tissues and prostate cancer cells [Abstract]. European Journal of Cancer 51 (S3), pp.S481. 2516. (10.1016/S0959-8049(15)30048-4)
- Tan, Y. et al., 2015. Interleukin-24 (IL-24) expression and biological impact on HECV endothelial cells.. Cancer Genomics and Proteomics 12 (5), pp.243-250.
2014
- Feng, X. et al., 2014. Regulation and involvement in cancer and pathological conditions of MAGI1, a tight junction protein. Anticancer Research 34 (7), pp.3251-3256.
- Frugtniet, B. et al. 2014. nWASP (neural Wiskott-Aldrich syndrome protein) is a novel therapeutic target in human wound healing [Conference Abstract]. Wound Repair and Regeneration 22 (5), pp.A80-A80. (10.1111/wrr.12218)
- Jia, J. et al., 2014. FAP-alpha (Fibroblast activation protein-alpha) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway. BMC Cell Biology 15 16. (10.1186/1471-2121-15-16)
- Jia, W. et al., 2014. The role of claudin-5 in blood-brain barrier ( BBB) and brain metastases (Review). Molecular Medicine Reports 9 (3), pp.779-785. (10.3892/mmr.2013.1875)
- Lane, J. et al. 2014. Structure and role of WASP and WAVE in Rho GTPase signalling in cancer. Cancer Genomics and Proteomics 11 (3), pp.155-165.
- Martin, T. A. 2014. The role of tight junctions in cancer metastasis. Seminars in Cell and Developmental Biology 36 , pp.224-231. (10.1016/j.semcdb.2014.09.008)
- Martin, T. A. and Jiang, W. G. 2014. Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma. Oncology Reports 31 (1), pp.262-272. (10.3892/or.2013.2813)
- Martin, T. A. , Mason, M. D. and Jiang, W. G. 2014. HGF and the regulation of tight junctions in human prostate cancer cells. Oncology Reports 32 (1), pp.213-224. (10.3892/or.2014.3219)
- Martin, T. A. et al. 2014. Brain-derived neurotrophic factor (bdnf) is a novel therapeutic agent in human wound healing [Abstract]. Wound Repair and Regeneration 22 (5), pp.A91. (10.1111/wrr.12218)
- Sun, T. T. et al., 2014. Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843 (3), pp.618-628. (10.1016/j.bbamcr.2013.12.013)
- Ye, L. et al. 2014. Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour-related angiogenesis. International Journal of Oncology 45 (4), pp.1565-1573. (10.3892/ijo.2014.2533)
2013
- Martin, T. A. and Jiang, W. G. 2013. Regulation of barrier function in human breast cancer can be controlled by the ROCK signalling pathway via interaction with SIPA-1 [Abstract]. European Journal of Cancer 49 , pp.S132-S132.
- Martin, T. A. et al. 2013. The expression of the Nectin complex in human breast cancer and the role of Nectin-3 in the control of tight junctions during metastasis. PLoS ONE 8 (12) e82696. (10.1371/journal.pone.0082696)
- Martin, T. A. et al. 2013. Claudin-20 promotes an aggressive phenotype in human breast cancer cells. Tissue Barriers 1 (3) e26518. (10.4161/tisb.26518)
- Martin, T. A. , Mason, M. D. and Jiang, W. G. 2013. HGF and the regulation of tight junctions in human prostate cancer cells. European Journal of Cancer 49 , pp.S132-S132.
- Martin, T. A. et al. 2013. Cancer invasion and metastasis: molecular and cellular perspective. In: Jandial, R. ed. Metastatic Cancer Clinical and Biological Perspectives. Austin, TX: Landes Bioscience. , pp.135-168.
- Wang, Y. , Martin, T. A. and Jiang, W. G. 2013. HAVcR-1 expression in human colorectal cancer and its effects on colorectal cancer cells in vitro.. Anticancer Research 33 (1), pp.207-214.
- Yang, X. , Martin, T. A. and Jiang, W. G. 2013. Biological influence of brain-derived neurotrophic factor (BDNF) on colon cancer cells. Experimental and Therapeutic Medicine 6 (6), pp.1475-1481. (10.3892/etm.2013.1330)
- Ye, L. et al. 2013. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 31 (8), pp.1576-1583. (10.1016/j.urolonc.2012.05.006)
2012
- Escudero-Esparza, A. , Jiang, W. G. and Martin, T. A. 2012. Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways. Journal of Experimental & Clinical Cancer Research 31 (1), pp.43-60. (10.1186/1756-9966-31-43)
- Ji, K. et al. 2012. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a rapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells. Cancer Genomics and Proteomics 9 (5), pp.321-327.
- Li, X. , Martin, T. A. and Jiang, W. G. 2012. COM-1/p8 acts as a tumour growth enhancer in colorectal cancer cell lines. Anticancer Research 32 (4), pp.1229-1237.
- Martin, T. A. et al. 2012. The clinical and biological implications of N-WASP expression in human colorectal cancer. Translational Gastrointestinal Cancer 1 (1), pp.10-20.
- Yang, X. , Martin, T. A. and Jiang, W. G. 2012. Biological influence of brain-derived neurotrophic factor on breast cancer cells. International Journal of Oncology 41 (4), pp.1541-1546. (10.3892/ijo.2012.1581)
2011
- Awsare, N. S. et al. 2011. Claudin-11 decreases the invasiveness of bladder cancer cells. Oncology Reports 25 (6), pp.1503-1509. (10.3892/or.2011.1244)
- Cheng, S. et al., 2011. Putative breast tumor suppressor TACC2 suppresses the aggressiveness of breast cancer cells through a PLCγ pathway. Current Signal Transduction Therapy 6 (1), pp.55-64. (10.2174/157436211794109361)
- Escudero-Esparza, A. , Jiang, W. G. and Martin, T. A. 2011. Claudin-5 participates in the regulation of endothelial cell motility. Molecular and Cellular Biochemistry 362 (1-2), pp.71-85. (10.1007/s11010-011-1129-2)
- Escudero-Esparza, A. , Jiang, W. G. and Martin, T. A. 2011. The Claudin family and its role in cancer and metastasis. Frontiers in Bioscience 16 (3), pp.1069-1083. (10.2741/3736)
- Lane, J. , Martin, T. A. and Jiang, W. G. 2011. HGF and rhoGTPases in cancer cell motility. Current Signal Transduction Therapy 6 (2), pp.173-179. (10.2174/157436211795660052)
- Martin, T. A. et al. 2011. HAVcR-1 reduces the integrity of human endothelial tight junctions. Anticancer Research 31 (2), pp.467-473.
- Martin, T. A. , Mason, M. D. and Jiang, W. G. 2011. Hepatocyte growth factor signalling in cancer metastasis. Current Signal Transduction Therapy 6 (2), pp.180-190. (10.2174/157436211795659991)
- Martin, T. A. , Mason, M. D. and Jiang, W. G. 2011. Tight junctions in cancer metastasis. Frontiers in Bioscience 16 (3), pp.898-936. (10.2741/3726)
- Minhas, U. et al. 2011. Pattern of expression of CCN family members Cyr61, CTGF and NOV in human acute and chronic wounds. Experimental and Therapeutic Medicine 2 (4), pp.641-645. (10.3892/etm.2011.256)
- Mustafa, N. , Martin, T. A. and Jiang, W. G. 2011. Metastasis tumour suppressor-1 and the aggressiveness of prostate cancer cells. Experimental and Therapeutic Medicine 2 (1), pp.157-162. (10.3892/etm.2010.184)
- Sanders, A. J. et al. 2011. EPLIN is a negative regulator of prostate cancer growth and invasion. The Journal of Urology 186 (1), pp.295-301. (10.1016/j.juro.2011.03.038)
2010
- Escudero-Esparza, A. et al. 2010. PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance. Oncology Reports 23 (2), pp.537-544. (10.3892/or_00000667)
- Herman, F. et al., 2010. Expression of the ERM family members (ezrin, radixin and moesin) in breast cancer. Experimental and Therapeutic Medicine 1 (1), pp.153-160. (10.3892/etm_00000025)
- Lane, J. et al. 2010. The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy. Journal of Experimental Therapeutics and Oncology 8 (3), pp.203-210.
- Lane, J. , Martin, T. A. and Jiang, W. G. 2010. Targeting RhoC by way of ribozyme trangene in human breast cancer cells and its impact on cancer invasion. World Journal of Oncology 1 (1), pp.7-13. (10.4021/wjon2010.01.1202)
- Martin, T. A. and Jiang, W. G. 2010. Hepatocyte growth factor and cMET, new development in cancer therapies [Editorial]. Anti-Cancer Agents in Medicinal Chemistry 10 (1), pp.1.
- Martin, T. A. and Jiang, W. G. 2010. Hepatocyte growth factor and its receptor signalling complex as targets in cancer therapy. Anti-Cancer Agents in Medicinal Chemistry 10 (1), pp.2-6.
- Martin, T. A. , Mansel, R. E. and Jiang, W. G. 2010. Loss of occludin leads to the progression of human breast cancer. International Journal of Molecular Medicine 26 (5), pp.723-734. (10.3892/ijmm_00000519)
2009
- Escudero-Esparza, A. et al. 2009. PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance. Cancer Genomics and Proteomics 6 (4), pp.239-246.
- Martin, T. A. and Jiang, W. G. 2009. Loss of tight junction barrier function and its role in cancer metastasis. Biochimica et Biophysica Acta (BBA) - Biomembranes 1788 (4), pp.872-891. (10.1016/j.bbamem.2008.11.005)
- Minhas, U. et al. 2009. CCN family proteins in wound healing - a pivotal role? [Abstract]. Wound Repair and Regeneration 17 (4), pp.A74. (10.1111/j.1524-475X.2009.00519.x)
2008
- Davies, G. et al. 2008. Phospholipase-C gamma-1 (PLCγ-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 26 (4), pp.386-391. (10.1016/j.urolonc.2007.06.003)
- Goyal, A. et al. 2008. Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome. World Journal of Surgical Oncology 6 , pp.56-61. (10.1186/1477-7819-6-56)
- Jiang, W. G. et al. 2008. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Molecular Cancer 7 71. (10.1186/1476-4598-7-71)
- Lane, J. et al. 2008. The expression and prognostic value of the guanine nucleotide exchange factors (GEFs) Trio, Vav1 and TIAM-1 in human breast cancer. International Seminars in Surgical Oncology 5 (1) 23. (10.1186/1477-7800-5-23)
- Lane, J. et al. 2008. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. International Journal of Oncology 33 (3), pp.585-593. (10.3892/ijo_00000044)
- Martin, T. A. et al. 2008. Claudin-16 reduces the aggressive behavior of human breast cancer cells. Journal of Cellular Biochemistry 105 (1), pp.41-52. (10.1002/jcb.21797)
- Sanders, A. J. et al. 2008. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation. Journal of Cellular Physiology 216 (3), pp.780-789. (10.1002/jcp.21460)
2007
- Martin, T. A. et al. 2007. N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer. Clinical & Experimental Metastasis 25 (2), pp.97-108. (10.1007/s10585-007-9120-8)
- Parr, C. et al., 2007. Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clinical Cancer Research 13 (12), pp.3568-3576. (10.1158/1078-0432.CCR-06-2357)
2006
- Harrison, G. et al., 2006. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells. Oncology Reports 15 (1), pp.199-206. (10.3892/or.15.1.199)
- Jiang, W. G. et al. 2006. Com-1/p8 acts as a putative tumour suppressor in prostate cancer. International Journal of Molecular Medicine 18 (5), pp.981-986.
- Lane, J. , Martin, T. A. and Jiang, W. G. 2006. Novel protein binding partners for Rho-associated serine-threonine protein kinases (ROCKS) in breast cancer cells [Abstract]. Breast Cancer Research and Treatment 100 (1 Supp), pp.S298-S298. 6127.
- Sanders, A. J. et al. 2006. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeutics and Oncology 6 (1), pp.39-48.
- Sanders, A. J. et al. 2006. Genetic reduction of matriptase-1 expressionj is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeautics and Oncology 6 (1), pp.39-48.
2005
- Jiang, W. et al. 2005. Manipulation of expression of MMP-14 and its impact on the invasivess and progression of breast cancer cells [Abstract]. Breast Cancer Research and Treatment 94 , pp.S187-S187.
- Jiang, W. G. et al. 2005. Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clinical Cancer Research 11 (16), pp.6012-6019. (10.1158/1078-0432.CCR-05-0275)
- Lane, J. , Martin, T. and Jiang, W. G. 2005. Targeting Rho-C by way of ribozyme transgene in human breast cancer cells and its impact on cancer invasion. Breast Cancer Research and Treatment 94 (1), pp.S188-S189. 4068. (10.1007/s10549-005-1234-6)
- Lane, J. , Martin, T. A. and Jiang, W. G. 2005. ROCK inhibitor Y-27632 suppresses the effect of HGF in human breast cancer cells [Abstract]. Breast Cancer Research and Treatment 94 (1 Supp), pp.S193-S194. 4082.
- Martin, T. A. et al. 2005. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Annals of Surgical Oncology 12 (6), pp.488-496. (10.1245/ASO.2005.04.010)
- Martin, T. A. et al. 2005. Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin. Histopathology 46 (4), pp.422-430. (10.1111/j.1365-2559.2005.02104.x)
2003
- Davies, G. et al., 2003. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesisin vivo. International Journal of Cancer 106 (3), pp.348-354. (10.1002/ijc.11220)
- Jiang, W. G. et al. 2003. Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET. Clinical Cancer Research 9 (11), pp.4274-4281.
- Martin, T. A. et al. 2003. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis 24 (8), pp.1317-1323. (10.1093/carcin/bgg072)
2001
- Jiang, W. G. et al. 2001. A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. Clinical Cancer Research 7 , pp.2555-2562.
- Martin, T. A. , Harding, K. G. and Jiang, W. G. 2001. Matrix-bound fibroblasts regulate angiogenesis by modulation of VE-cadherin. European Journal of Clinical Investigation 31 (11), pp.931-938. (10.1046/j.1365-2362.2001.00914.x)
- Martin, T. A. and Jiang, W. G. 2001. Tight junctions and their role in cancer metastasis.. Histology and Histopathology 16 , pp.1183-1195.
- Martin, T. A. , Mansel, R. E. and Jiang, W. G. 2001. Hepatocyte growth factor modulates vascular endothelial-cadherin expresssion in human endothelial cells. Clinical Cancer Research 7 (3), pp.734-737.
1999
- Jiang, W. G. et al. 1999. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clinical Cancer Research 5 (11), pp.3695-3703.
- Jiang, W. G. et al. 1999. Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells.. Journal of Cellular Physiology 181 (2), pp.219-329. (10.1002/(SICI)1097-4652(199911)181:2<319::AID-JCP14>3.0.CO;2-S)
Articles
- Ali, A. Y. et al. 2015. Anti-metastatic and cytotoxic properties of frankincense and scented myrrh. Anticancer Research 35 (7), pp.4310-4311.
- Awsare, N. S. et al. 2011. Claudin-11 decreases the invasiveness of bladder cancer cells. Oncology Reports 25 (6), pp.1503-1509. (10.3892/or.2011.1244)
- Cheng, S. et al., 2011. Putative breast tumor suppressor TACC2 suppresses the aggressiveness of breast cancer cells through a PLCγ pathway. Current Signal Transduction Therapy 6 (1), pp.55-64. (10.2174/157436211794109361)
- Cong, B. et al., 2026. MLN51 (Metastatic Lymph Node Gene 51)/CASC3 (Cancer Susceptibility Candidate Gene 3), A putative tumour suppressor in breast cancer, the clinical and therapeutic connections. Breast Cancer: Targets and Therapy 18
- Cong, Y. et al., 2020. Tim-3 promotes cell aggressiveness and paclitaxel resistance through the NF-κB /STAT3 signalling pathway in breast cancer cells. Chinese Journal of Cancer Research 32 (5), pp.564-579. (10.21147/j.issn.1000-9604.2020.05.02)
- Davies, G. et al. 2008. Phospholipase-C gamma-1 (PLCγ-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 26 (4), pp.386-391. (10.1016/j.urolonc.2007.06.003)
- Davies, G. et al., 2003. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesisin vivo. International Journal of Cancer 106 (3), pp.348-354. (10.1002/ijc.11220)
- Escudero-Esparza, A. , Jiang, W. G. and Martin, T. A. 2012. Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways. Journal of Experimental & Clinical Cancer Research 31 (1), pp.43-60. (10.1186/1756-9966-31-43)
- Escudero-Esparza, A. , Jiang, W. G. and Martin, T. A. 2011. Claudin-5 participates in the regulation of endothelial cell motility. Molecular and Cellular Biochemistry 362 (1-2), pp.71-85. (10.1007/s11010-011-1129-2)
- Escudero-Esparza, A. , Jiang, W. G. and Martin, T. A. 2011. The Claudin family and its role in cancer and metastasis. Frontiers in Bioscience 16 (3), pp.1069-1083. (10.2741/3736)
- Escudero-Esparza, A. et al. 2009. PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance. Cancer Genomics and Proteomics 6 (4), pp.239-246.
- Escudero-Esparza, A. et al. 2010. PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance. Oncology Reports 23 (2), pp.537-544. (10.3892/or_00000667)
- Fang, X. , Jiang, W. G. and Martin, T. A. 2015. The role of claudin-5 in the cell-cell adhesion of human keratinocytes. Anticancer Research 35 (7), pp.4367.
- Feng, X. et al., 2014. Regulation and involvement in cancer and pathological conditions of MAGI1, a tight junction protein. Anticancer Research 34 (7), pp.3251-3256.
- Frugtniet, B. , Jiang, W. G. and Martin, T. A. 2015. Investigating the effect of NWASP (Neural Wiskott-Aldrich Syndrome Protein) inhibitors on human lung cancer cell behaviour. Anticancer Research 35 (7), pp.4348-4349.
- Frugtniet, B. , Jiang, W. G. and Martin, T. A. 2015. Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis. Breast Cancer: Targets and Therapy 2015 (7), pp.99-109. (10.2147/BCTT.S59006)
- Frugtniet, B. et al. 2014. nWASP (neural Wiskott-Aldrich syndrome protein) is a novel therapeutic target in human wound healing [Conference Abstract]. Wound Repair and Regeneration 22 (5), pp.A80-A80. (10.1111/wrr.12218)
- Frugtniet, B. A. et al. 2017. Neural Wiskott-Aldrich syndrome protein (nWASP) is implicated in human lung cancer invasion. BMC Cancer 17 (1) 224. (10.1186/s12885-017-3219-3)
- Frugtniet, B. A. et al. 2023. nWASP inhibition increases wound healing via TrKb/PLCγ signalling. Biomolecules 13 (2) 379. (10.3390/biom13020379)
- Gao, H. et al., 2022. P-211 Claudin-16, its clinical and prognostic value in colorectal cancer. Annals of Oncology 33 , pp.S324-S324. (10.1016/j.annonc.2022.04.301)
- Gong, W. et al., 2020. Influence of anaesthetics on the production of cancer cell motogens, stromal cell-derived factor-1 and hepatocyte growth factor by fibroblasts. Oncology Letters 21 (2) 140. (10.3892/ol.2020.12401)
- Gong, W. et al., 2021. Location, function and role of stromal cell-derived factors and possible implications in cancer. International Journal of Molecular Medicine 47 (2), pp.435-443. (10.3892/ijmm.2020.4811)
- Goyal, A. et al. 2008. Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome. World Journal of Surgical Oncology 6 , pp.56-61. (10.1186/1477-7819-6-56)
- Gu, Y. et al., 2017. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway. Oncotarget 8 (5), pp.7753-7765. (10.18632/oncotarget.13949)
- Harrison, G. et al., 2006. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells. Oncology Reports 15 (1), pp.199-206. (10.3892/or.15.1.199)
- Herman, F. et al., 2010. Expression of the ERM family members (ezrin, radixin and moesin) in breast cancer. Experimental and Therapeutic Medicine 1 (1), pp.153-160. (10.3892/etm_00000025)
- Ismail, A. F. et al., 2017. PAK5 mediates cell: cell adhesion integrity via interaction with E-cadherin in bladder cancer cells. Biochemical Journal 474 (8), pp.1333-1346. (10.1042/BCJ20160875)
- Ji, K. et al. 2012. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a rapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells. Cancer Genomics and Proteomics 9 (5), pp.321-327.
- Ji, W. et al. 2025. Knockdown of claudin-8 (CLDN8) indicates a link between breast cancer cell sensitivity to chemotherapeutics and reveals a potential use of CLDN8 as a molecular diagnostic and target for therapy. International Journal of Molecular Sciences 26 (11) 5412. (10.3390/ijms26115412)
- Ji, W. et al. 2025. Tight junctional protein family, Claudins in cancer and cancer metastasis. Frontiers in Oncology 15 1596460. (10.3389/fonc.2025.1596460)
- Jia, J. et al., 2018. Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways. International Journal of Molecular Medicine 41 (1), pp.275-283. (10.3892/ijmm.2017.3224)
- Jia, J. et al., 2014. FAP-alpha (Fibroblast activation protein-alpha) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway. BMC Cell Biology 15 16. (10.1186/1471-2121-15-16)
- Jia, W. et al., 2015. Epithelial-mesenchymal transition (EMT) markers in human pituitary adenomas indicate a clinical course. Anticancer Research 35 (5), pp.2635-2643.
- Jia, W. et al., 2015. Expression of metastasis-associated gene-1 is associated with bone invasion and tumor stage in human pituitary adenomas. Cancer Genomics and Proteomics 12 (3), pp.113-118.
- Jia, W. et al., 2016. Expression of the Epithelial-Mesenchymal-Transition (EMT) markers, Twist, Slug, Snail, E- and N-cadherins and the association with clinical and pathological features of human pituitary adenomas [Abstract]. European Journal of Cancer 51 (S3), pp.S592-S593. 2925. (10.1016/S0959-8049(15)30055-1)
- Jia, W. et al., 2014. The role of claudin-5 in blood-brain barrier ( BBB) and brain metastases (Review). Molecular Medicine Reports 9 (3), pp.779-785. (10.3892/mmr.2013.1875)
- Jia, W. et al., 2015. Association of mta-1 expression in pituitary tumours with bone invasion. Anticancer Research 35 (7), pp.4360.
- Jiang, W. et al. 2005. Manipulation of expression of MMP-14 and its impact on the invasivess and progression of breast cancer cells [Abstract]. Breast Cancer Research and Treatment 94 , pp.S187-S187.
- Jiang, W. G. et al. 2006. Com-1/p8 acts as a putative tumour suppressor in prostate cancer. International Journal of Molecular Medicine 18 (5), pp.981-986.
- Jiang, W. G. et al. 2005. Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clinical Cancer Research 11 (16), pp.6012-6019. (10.1158/1078-0432.CCR-05-0275)
- Jiang, W. G. et al. 2001. A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. Clinical Cancer Research 7 , pp.2555-2562.
- Jiang, W. G. et al. 2003. Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET. Clinical Cancer Research 9 (11), pp.4274-4281.
- Jiang, W. G. et al. 1999. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clinical Cancer Research 5 (11), pp.3695-3703.
- Jiang, W. G. et al. 2008. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Molecular Cancer 7 71. (10.1186/1476-4598-7-71)
- Jiang, W. G. et al. 1999. Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells.. Journal of Cellular Physiology 181 (2), pp.219-329. (10.1002/(SICI)1097-4652(199911)181:2<319::AID-JCP14>3.0.CO;2-S)
- Jiang, W. G. et al. 2015. YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells. Journal of Translational Medicine 13 280. (10.1186/s12967-015-0639-1)
- Lane, J. , Martin, T. and Jiang, W. G. 2005. Targeting Rho-C by way of ribozyme transgene in human breast cancer cells and its impact on cancer invasion. Breast Cancer Research and Treatment 94 (1), pp.S188-S189. 4068. (10.1007/s10549-005-1234-6)
- Lane, J. et al. 2010. The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy. Journal of Experimental Therapeutics and Oncology 8 (3), pp.203-210.
- Lane, J. , Martin, T. A. and Jiang, W. G. 2011. HGF and rhoGTPases in cancer cell motility. Current Signal Transduction Therapy 6 (2), pp.173-179. (10.2174/157436211795660052)
- Lane, J. , Martin, T. A. and Jiang, W. G. 2006. Novel protein binding partners for Rho-associated serine-threonine protein kinases (ROCKS) in breast cancer cells [Abstract]. Breast Cancer Research and Treatment 100 (1 Supp), pp.S298-S298. 6127.
- Lane, J. , Martin, T. A. and Jiang, W. G. 2005. ROCK inhibitor Y-27632 suppresses the effect of HGF in human breast cancer cells [Abstract]. Breast Cancer Research and Treatment 94 (1 Supp), pp.S193-S194. 4082.
- Lane, J. , Martin, T. A. and Jiang, W. G. 2010. Targeting RhoC by way of ribozyme trangene in human breast cancer cells and its impact on cancer invasion. World Journal of Oncology 1 (1), pp.7-13. (10.4021/wjon2010.01.1202)
- Lane, J. et al. 2008. The expression and prognostic value of the guanine nucleotide exchange factors (GEFs) Trio, Vav1 and TIAM-1 in human breast cancer. International Seminars in Surgical Oncology 5 (1) 23. (10.1186/1477-7800-5-23)
- Lane, J. et al. 2008. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. International Journal of Oncology 33 (3), pp.585-593. (10.3892/ijo_00000044)
- Lane, J. et al. 2014. Structure and role of WASP and WAVE in Rho GTPase signalling in cancer. Cancer Genomics and Proteomics 11 (3), pp.155-165.
- Li, A. X. et al., 2024. Cellular impacts of striatins and the STRIPAK complex and their roles in the development and metastasis in clinical cancers. Cancers 16 (1) 76. (10.3390/cancers16010076)
- Li, A. X. et al. 2023. Striatins and the STRIPAK complex partners in the clinical outcome of patients with breast cancer and responses to drug treatment. Chinese Journal of Cancer Research 35 , pp.365-385. (10.21147/j.issn.1000-9604.2023.04.04)
- Li, A. X. et al. 2024. Metastatic Lymph Node 64 (MLN64) expression in gastric cancer, the clinical and molecular implications in drug resistance. Cancer Genomics & Proteomics 21 (1), pp.30-40. (10.21873/cgp.20427)
- Li, X. , Martin, T. A. and Jiang, W. G. 2012. COM-1/p8 acts as a tumour growth enhancer in colorectal cancer cell lines. Anticancer Research 32 (4), pp.1229-1237.
- Liu, C. et al. 2020. The role of SIPA1 in the development of cancer and metastases (Review). Molecular and Clinical Oncology 13 (4) 32. (10.3892/mco.2020.2102)
- Liu, C. et al. 2021. SIPA1 Is a modulator of HGF/MET induced tumour metastasis via the regulation of tight junction-based cell to cell barrier function. Cancers 13 (7) 1747. (10.3390/cancers13071747)
- Liu, R. et al., 2015. Metastasis suppressor 1 (MTSS1) expression in human ovarian cancer; the impact on cellular migration and metastasis [Abstract]. Anticancer Research 35 (7), pp.4342-4342.
- Liu, R. et al., 2016. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer. International Journal of Oncology 48 (6), pp.2488-2496. (10.3892/ijo.2016.3462)
- Liu, R. et al., 2015. Metastasis suppressor 1 expression in human ovarian cancer: the impact on cellular migration and metastasis. International Journal of Oncology 47 (4), pp.1429-1439. (10.3892/ijo.2015.3121)
- Martin, T. A. et al. 2021. NUPR1 and its potential role in cancer and pathological conditions (Review). International Journal of Oncology 58 (5) 21. (10.3892/ijo.2021.5201)
- Martin, T. A. 2014. The role of tight junctions in cancer metastasis. Seminars in Cell and Developmental Biology 36 , pp.224-231. (10.1016/j.semcdb.2014.09.008)
- Martin, T. A. et al. 2005. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Annals of Surgical Oncology 12 (6), pp.488-496. (10.1245/ASO.2005.04.010)
- Martin, T. A. , Harding, K. G. and Jiang, W. G. 2001. Matrix-bound fibroblasts regulate angiogenesis by modulation of VE-cadherin. European Journal of Clinical Investigation 31 (11), pp.931-938. (10.1046/j.1365-2362.2001.00914.x)
- Martin, T. A. et al. 2011. HAVcR-1 reduces the integrity of human endothelial tight junctions. Anticancer Research 31 (2), pp.467-473.
- Martin, T. A. et al. 2008. Claudin-16 reduces the aggressive behavior of human breast cancer cells. Journal of Cellular Biochemistry 105 (1), pp.41-52. (10.1002/jcb.21797)
- Martin, T. A. and Jiang, W. G. 2014. Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma. Oncology Reports 31 (1), pp.262-272. (10.3892/or.2013.2813)
- Martin, T. A. and Jiang, W. G. 2010. Hepatocyte growth factor and cMET, new development in cancer therapies [Editorial]. Anti-Cancer Agents in Medicinal Chemistry 10 (1), pp.1.
- Martin, T. A. and Jiang, W. G. 2010. Hepatocyte growth factor and its receptor signalling complex as targets in cancer therapy. Anti-Cancer Agents in Medicinal Chemistry 10 (1), pp.2-6.
- Martin, T. A. and Jiang, W. G. 2009. Loss of tight junction barrier function and its role in cancer metastasis. Biochimica et Biophysica Acta (BBA) - Biomembranes 1788 (4), pp.872-891. (10.1016/j.bbamem.2008.11.005)
- Martin, T. A. and Jiang, W. G. 2013. Regulation of barrier function in human breast cancer can be controlled by the ROCK signalling pathway via interaction with SIPA-1 [Abstract]. European Journal of Cancer 49 , pp.S132-S132.
- Martin, T. A. and Jiang, W. G. 2001. Tight junctions and their role in cancer metastasis.. Histology and Histopathology 16 , pp.1183-1195.
- Martin, T. A. et al. 2016. Metastasis to bone in human cancer is associated with loss of occludin expression. Anticancer Research 36 (3), pp.1287-1294.
- Martin, T. A. et al. 2015. Comparison of blood brain barrier endothelia reveals a differential expression of tight junction proteins [Abstract]. Anticancer Research 35 (7), pp.4357-4358.
- Martin, T. A. et al. 2013. The expression of the Nectin complex in human breast cancer and the role of Nectin-3 in the control of tight junctions during metastasis. PLoS ONE 8 (12) e82696. (10.1371/journal.pone.0082696)
- Martin, T. A. et al. 2013. Claudin-20 promotes an aggressive phenotype in human breast cancer cells. Tissue Barriers 1 (3) e26518. (10.4161/tisb.26518)
- Martin, T. A. , Mansel, R. E. and Jiang, W. G. 2001. Hepatocyte growth factor modulates vascular endothelial-cadherin expresssion in human endothelial cells. Clinical Cancer Research 7 (3), pp.734-737.
- Martin, T. A. , Mansel, R. E. and Jiang, W. G. 2010. Loss of occludin leads to the progression of human breast cancer. International Journal of Molecular Medicine 26 (5), pp.723-734. (10.3892/ijmm_00000519)
- Martin, T. A. , Mason, M. D. and Jiang, W. G. 2011. Hepatocyte growth factor signalling in cancer metastasis. Current Signal Transduction Therapy 6 (2), pp.180-190. (10.2174/157436211795659991)
- Martin, T. A. , Mason, M. D. and Jiang, W. G. 2014. HGF and the regulation of tight junctions in human prostate cancer cells. Oncology Reports 32 (1), pp.213-224. (10.3892/or.2014.3219)
- Martin, T. A. , Mason, M. D. and Jiang, W. G. 2013. HGF and the regulation of tight junctions in human prostate cancer cells. European Journal of Cancer 49 , pp.S132-S132.
- Martin, T. A. , Mason, M. D. and Jiang, W. G. 2011. Tight junctions in cancer metastasis. Frontiers in Bioscience 16 (3), pp.898-936. (10.2741/3726)
- Martin, T. A. et al. 2003. Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis 24 (8), pp.1317-1323. (10.1093/carcin/bgg072)
- Martin, T. A. et al. 2007. N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer. Clinical & Experimental Metastasis 25 (2), pp.97-108. (10.1007/s10585-007-9120-8)
- Martin, T. A. et al. 2014. Brain-derived neurotrophic factor (bdnf) is a novel therapeutic agent in human wound healing [Abstract]. Wound Repair and Regeneration 22 (5), pp.A91. (10.1111/wrr.12218)
- Martin, T. A. , Telford, E. and Jiang, W. G. 2015. HAVCR1 is a potential prognostic factor in human breast cancer. Anticancer Research 35 (7), pp.4327.
- Martin, T. A. and Tiang, W. G. 2015. The blood brain barrier and the prevention of metastatic disease. Anticancer Research 35 (7), pp.4298-4299.
- Martin, T. A. et al. 2012. The clinical and biological implications of N-WASP expression in human colorectal cancer. Translational Gastrointestinal Cancer 1 (1), pp.10-20.
- Martin, T. A. et al. 2005. Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin. Histopathology 46 (4), pp.422-430. (10.1111/j.1365-2559.2005.02104.x)
- Men, W. et al., 2015. Expression of claudins in human clear cell renal cell carcinoma. Cancer Genomics and Proteomics 12 (1), pp.1-8.
- Minhas, U. et al. 2009. CCN family proteins in wound healing - a pivotal role? [Abstract]. Wound Repair and Regeneration 17 (4), pp.A74. (10.1111/j.1524-475X.2009.00519.x)
- Minhas, U. et al. 2011. Pattern of expression of CCN family members Cyr61, CTGF and NOV in human acute and chronic wounds. Experimental and Therapeutic Medicine 2 (4), pp.641-645. (10.3892/etm.2011.256)
- Mustafa, N. , Martin, T. A. and Jiang, W. G. 2011. Metastasis tumour suppressor-1 and the aggressiveness of prostate cancer cells. Experimental and Therapeutic Medicine 2 (1), pp.157-162. (10.3892/etm.2010.184)
- O’Neill, N. S. et al. 2025. Correlation of GD2 biosynthesis enzymes with cancer stem cell markers in human breast cancer. Cancer Genomics & Proteomics 22 (2), pp.231-246. (10.21873/cgp.20498)
- Owen, S. et al., 2015. An investigation of Amphiphysin II transcript expression in pituitary adenomas [Abstract]. European Journal of Cancer 51 (S3), pp.S580-S580. 2806. (10.1016/S0959-8049(15)30053-8)
- Owen, S. et al., 2015. The prostate Transglutaminase, TGase-4, is potentially linked to the junctional proteins at tight junctions of prostate tissues and prostate cancer cells [Abstract]. European Journal of Cancer 51 (S3), pp.S481. 2516. (10.1016/S0959-8049(15)30048-4)
- Parr, C. et al., 2007. Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clinical Cancer Research 13 (12), pp.3568-3576. (10.1158/1078-0432.CCR-06-2357)
- Sanders, A. J. et al. 2011. EPLIN is a negative regulator of prostate cancer growth and invasion. The Journal of Urology 186 (1), pp.295-301. (10.1016/j.juro.2011.03.038)
- Sanders, A. J. et al. 2006. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeutics and Oncology 6 (1), pp.39-48.
- Sanders, A. J. et al. 2006. Genetic reduction of matriptase-1 expressionj is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeautics and Oncology 6 (1), pp.39-48.
- Sanders, A. J. et al. 2008. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation. Journal of Cellular Physiology 216 (3), pp.780-789. (10.1002/jcp.21460)
- Sui, L. et al. 2022. P-282 Impact of death-associated protein-3 (DAP3) and DAP3 binding cell death enhancer 1 (DELE1) on drug sensitivity in colorectal cancer cells. Annals of Oncology 33 , pp.S347. (10.1016/j.annonc.2022.04.371)
- Sui, L. et al. 2022. Death associated protein-3 (DAP3) and DAP3 binding cell death enhancer-1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance. International Journal of Oncology 62 (1) 7. (10.3892/ijo.2022.5455)
- Sun, T. T. et al., 2014. Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843 (3), pp.618-628. (10.1016/j.bbamcr.2013.12.013)
- Tan, Y. et al., 2015. Interleukin-24 (IL-24) expression and biological impact on HECV endothelial cells.. Cancer Genomics and Proteomics 12 (5), pp.243-250.
- Telford, E. , Jiang, W. G. and Martin, T. A. 2017. HAVcR-1 involvement in cancer progression. Histology and Histopathology 32 , pp.121-128. (10.14670/HH-11-817)
- Telford, E. A. et al. 2022. Hepatitis A virus cellular receptor 1 (HAVcr-1) initiates prostate cancer progression in human cells via hepatocyte growth factor (HGF)-induced changes in junctional integrity. Biomolecules 12 (2) 338. (10.3390/biom12020338)
- Tong, J. et al. 2025. DRIM modulates Src activation and regulates angiogenic functions in vascular endothelial cells. Cell Biology International 49 (3), pp.277-287. (10.1002/cbin.12265)
- Wang, Y. , Martin, T. A. and Jiang, W. G. 2013. HAVcR-1 expression in human colorectal cancer and its effects on colorectal cancer cells in vitro.. Anticancer Research 33 (1), pp.207-214.
- Wazir, U. et al., 2025. CD84 as a prognostic biomarker and therapeutic target in breast cancer: Interconnections with PDL1, CD74, and immune tolerance mechanisms. Cancer Genomics & Proteomics 22 (4), pp.557-563. (10.21873/cgp.20521)
- Wazir, U. et al., 2019. Correlation of TERT and stem cell markers in the context of human breast cancer. Cancer Genomics and Proteomics 16 (2), pp.121-127. (10.21873/cgp.20117)
- Wazir, U. et al., 2020. Stratification using hTERT and stem cell markers confers a good prognosis in invasive breast cancer. Cancer Genomics and Proteomics 17 (2), pp.169-174. (10.21873/cgp.20177)
- Xin, L. et al., 2021. SIKs suppress tumor function and regulate drug resistance in breast cancer. American Journal of Cancer Research 11 (7), pp.3537-3557.
- Xin, L. et al. 2017. The era of multigene panels comes? The clinical utility of Oncotype DX and MammaPrint. World Journal of Oncology 8 (2), pp.34-40. (10.14740/wjon1019w)
- Xu, Y. et al., 2019. BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis. European Review for Medical and Pharmacological Sciences 23 (12), pp.5093-5100. (10.26355/eurrev_201906_18173)
- Yang, X. et al., 2017. A novel NHERF1 mutation in human breast cancer and effects on malignant progression. Anticancer Research 37 (1), pp.67-73. (10.21873/anticanres.11290)
- Yang, X. , Martin, T. A. and Jiang, W. G. 2013. Biological influence of brain-derived neurotrophic factor (BDNF) on colon cancer cells. Experimental and Therapeutic Medicine 6 (6), pp.1475-1481. (10.3892/etm.2013.1330)
- Yang, X. , Martin, T. A. and Jiang, W. G. 2012. Biological influence of brain-derived neurotrophic factor on breast cancer cells. International Journal of Oncology 41 (4), pp.1541-1546. (10.3892/ijo.2012.1581)
- Yang, X. et al., 2016. The impact of TIMM17A on aggressiveness of human breast cancer cells. Anticancer Research 36 (3), pp.1237-1241.
- Ye, L. et al. 2013. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 31 (8), pp.1576-1583. (10.1016/j.urolonc.2012.05.006)
- Ye, L. et al. 2014. Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour-related angiogenesis. International Journal of Oncology 45 (4), pp.1565-1573. (10.3892/ijo.2014.2533)
- Yu, R. Y. , Jiang, W. G. and Martin, T. A. 2025. The WASP/WAVE protein family in breast cancer and their role in the metastatic cascade. Cancer Genomics & Proteomics 22 (2), pp.166-187. (10.21873/cgp.20495)
- Zeng, J. et al. 2024. EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancer. Scientific Reports 14 (1) 30850. (10.1038/s41598-024-81485-w)
- Zhao, H. et al. 2016. The clinical implications of RSK1-3 in human breast cancer. Anticancer Research 36 (3), pp.1267-1274.
- Zhao, H. et al., 2017. The effect of aurora kinase inhibitor on adhesion and migration in human breast cancer cells and clinical implications. World Journal of Oncology 8 (5), pp.151-161. (10.14740/wjon1062w)
- Zhao, H. et al. 2016. Effect of junctional adhesion molecule-2 expression on cell growth, invasion and migration in human colorectal cancer. International Journal of Oncology 48 (3), pp.929-936. (10.3892/ijo.2016.3340)
- Zhao, H. et al. 2016. The role of JAM-B in cancer and cancer metastasis (Review). Oncology Reports 36 , pp.3-9. (10.3892/or.2016.4773)
- Zhu, K. et al., 2024. Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-β/Smad signal pathway. Journal of Neuro-Oncology 170 , pp.331-345. (10.1007/s11060-024-04797-x)
- Zhu, K. et al., 2025. Tumor exosomal miR-221-3p induces glycolysis through the LIFR/GLUT1 pathway to destroy the cerebral vascular endothelial cell barrier and promote breast cancer brain metastasis. Journal of Translational Medicine 23 (1) 1333. (10.1186/s12967-025-07372-8)
- Zhuang, X. et al. 2023. Claudin-10 in the blood brain barrier function of cerebral endothelial cells and transendothelial invasion of breast cancer cells. Anticancer Research 43 (9), pp.3923-3934. (10.21873/anticanres.16580)
- Zhuang, X. et al., 2023. Expression of Claudin-9 (CLDN9) in breast cancer, the clinical significance in connection with its subcoat anchorage proteins ZO-1 and ZO-3 and impact on drug resistance. Biomedicines 11 (12) 3136. (10.3390/biomedicines11123136)
Book sections
- Martin, T. A. et al. 2013. Cancer invasion and metastasis: molecular and cellular perspective. In: Jandial, R. ed. Metastatic Cancer Clinical and Biological Perspectives. Austin, TX: Landes Bioscience. , pp.135-168.
Conferences
- Zhao, Z. et al. 2020. Abstract P2-07-01: Kidins220 (kinase D interacting substrate 220) has a connection with neutrotrophic related factors, BDNF and NGF, in human breast cancer. Presented at: San Antonio Breast Cancer Symposium San Antonio, TX, United States 10-14 December 2019. Vol. 80.Vol. 4, Sup. , pp.P2-07-01. (10.1158/1538-7445.SABCS19-P2-07-01)
- Zhao, Z. et al. 2020. Abstract P3-01-18: Kinase D interacting substrate 220 (Kidins220) and disease progression of breast cancer, the role of heat shock protein90 (HSP90). Presented at: San Antonio Breast Cancer Symposium San Antonio, TX, United States 10-14 December 2019. Vol. 80.Vol. 4, Sup. American Association for Cancer Research. , pp.P3-01-18. (10.1158/1538-7445.SABCS19-P3-01-18)
Research
Cell junctions as mediators or barriers to cell dissemination and the regulators thereof
- The Tight Junction (TJ) is a region where the plasma membrane of adjacent cells forms a series of contacts that appear to completely occlude the extracellular space thus creating an intercellular barrier and intramembrane diffusion fence.
- In epithelial cells the TJ functions in an adhesive manner and can prevent cell dissociation whereas TJs in endothelial cells function as a barrier through which molecules and inflammatory cells can pass.
- A considerable body of now work exists on TJ and their role in a number of diseases.
- TJs have become recognised as key players in cancer metastasis. Early studies suggested a link between the reduction of TJ proteins and tumour differentiation and increasing experimental evidence has emerged to place TJs in the frontline as the structure that cancer cells must overcome in order to metastasize.
- Interaction and penetration of the vascular endothelium by dissociated cancer cells is an important step in the formation of cancer metastases.
- Changes in both tumour and endothelial cells are necessary for successful growth and spread of cancer cells and that these changes are somewhat similar.
- A change in cancer cells by up-regulation or down-regulation of relevant TJ proteins results in loss of cell–cell association, cell contact inhibition, leading to uncontrolled growth, loss of adhesion to and degradation of the basement.
- These must be a concurrent loss of cell–cell association in the endothelium and modulation of TJ proteins involved in facilitating the passage of the cancer cells through this barrier.
- We have shown there is a differential expression of a number of transmembrane TJ proteins, notably Occludin, Claudin-5 and the Nectin and that they are correlated with the disruption of TJs in tumours.
- Modulation of expression of these proteins results in key changes in barrier function leading to the progression of cancer and progression of metastasis.
Areas of research
Minimally invasive treatments:
- Novel minimally invasive therapeutic technology
Blood brain barrier (BBB):
- Modulators of BBB dynamics
- Comparison of different BBB endothelial cells and the role of HGF in brain metastasis.
HAVcR-1:
- Function of HAVcR-1 in breast cancer and its control of barrier function.
- HAVcR-1 as a significant modulator of HGF signalling in prostate cancer metastasis via the control of TJs.
Occludin and MARVELD3:
- Control of TJ function by Occludin/MARVELD3 and and different isoforms in breast and colorectal cancer metastasis.
Signalling and control of TJs:
- How SIPA-1 is integrated into the HGF signalling pathway of TJ function in breast cancer.
- Exploration of N-Wasp and WAVE family members in TJ function and metastasis.
- BDNf/NGF and the metastatic cascade.
Teaching
Undergraduate research supervision:
- SSC component of year 1, 2, 3 and 4 C21 MB BCh, research placements and electives
- PTY and ad hoc research project placements
- Intercalated projects
- Medical Pharmacology projects
Undergraduate teaching:
- SSC Literature project year 1 C21 MB BCh
- PCS year 1 C21 MB BCh
Postgraduate teaching:
- MSc Cancer and Therapeutics
- MSc project supervising
Biography
Career overview
Team Leader and Senior Lecturer: My research interests are investigating the role of Tight Junctions in the progression of cancer, and investigating how they can be modulated in both benign and pathological disease, with a focus on metastatic brain disease. I also have a continued interest in angiogenic factors and their role in metastasis. I supervise a large number of PhD, MD and visiting research fellows, attend national and international conferences (I have presented over 70 papers), write original research papers, reviews (many invited) and book chapters (invited). During the last 10 years, I was employed to work on 2 major projects as a research scientist: the first was sponsored by Abbot Pharmaceuticals (2003-2005) and involved investigating factors that could affect benign and malignant breast cancer cells in regards to cellular "leakiness". This directly involved Tight Junctions as controllers.
2003 - 2020 Lecturer: Developing a research focau on Tight Junctions in cacner and metastatic disease. From 2006-2011 I was employed as the research scientist on a Cancer-Research Wales sponsored program grant. This involved the examination of Hepatocyte Growth Factor (HGF) and how this cytokine influences stem cells markers in breast and prostate cancer (funded by Cancer Research Wales). This work led to the award of the AACR-CTR-SABSC-Susan G, Komen for the Cure Scholarship for "Evaluation of the distribution of stem cell markers (PSCA, CD44, CD49b and CD133) in human breast cancer reveals correlation with clinical progression and metastatic disease in ductal carcinoma".
March 2000 - July 2003 Research Fellow: Undertook a program of research to determine, using molecular, cellular and in vivo techniques, the mechanisms of cancer metastasis in particular the possible application of newly discovered antagonists to growth factors as an anti-metastasis tool (Susan G. Komen Breast Cancer Foundation for a study on 'NK4, a HGF/SF antagonist, as a new anti-metastatic-agent in breast cancer). This was followed by a project sponsored by CR-UK that involved the creation of an anti-metastasis/angiogenesis compound. I also began to research the role that Tight Junctions and their molecular constituents may have in breast cancer metastasis. This research was recognised at the 2002 San Antonio Breast Cancer Symposium, where I was honoured with an Astra-Zeneca Scholar Awards showing that tight junction molecules are lost in those patients with metastatic breast cancer.
June 1997- March 2000 Research Fellow: Establishing the role of fibroblasts in the process of tissue repair and cancer metastasis, identifying fibroblast derived factors responsible for the regulatory effect of fibroblasts, in the promotion of angiogenesis, at the Wound Healing Research Unit, University Department of Surgery at UWCM, Cardiff, UK for Prof. K.G. Harding (funded by Smith & Nephew/Advanced Tissue Science Joint Venture).
Education and qualifications
- 2020: iACT Manager
- 2013: University Leadership and Management (ILM).
- 1996: PhD: The Use of 16S ribosomal RNA to Investigate Microbial Diversity of River Epilithon at the Department of Pure & Applied Biology University of Wales College Cardiff.
- 1992: BSc (hons) Microbiology & Genetics, Department of Pure & Applied Biology University of Wales College Cardiff. Honours Research Project: The Effect of Toxic Metal & Other External Factors on the Growth of the Basidiomycete Fungi Hypholoma fasciculare.
Honours and awards
BACR Travel Award to the 7th Chinese Conference on Oncology (CCO) and The 11th Cross-Strait Academic Conference on Oncology and the China-UK-Japan Gastro-intestinal Cancer Symposium, 2012.
AACR Scholar-in Training Award, funded by Susan G. Komen for the Cure at the CTRC-AACR San Antonio Breast Cancer Symposium, Texas, December 2009 for "Evaluation of the distribution of stem cell markers in human breast cancer reveals correlation with clinical progression and metastatic disease in ductal carcinoma".
Welsh Urologists March 2006 Asware N., Martin T.A., Matthews P.N., Jiang W.G. Welsh Urologists March 2003 Brown G.M., Martin T.A., Matthews P.N., Jiang W.G. "The expression of tight junction molecules in human bladder cancer"
San Antonio Breast Cancer Symposium, December 2004 Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG. "ROCK1 and the aggressive nature of breast cancer cells".
Welsh Urologists March 2003 Brown G.M., Martin T.A., Matthews P.N., Jiang W.G. "The expression of tight junction molecules in human bladder cancer"
Astra-Zeneca Scholar at the San Antonio Breast Cancer Symposium, December 2002 for "Expression and distribution of tight junction molecules in breast cancer and their association with clinical outcomes" and invited give an oral presentation.
AACR Scholarship April 2002 Davies G, Martin TA, Parr C, Grimshaw D, Mason MD, Jiang WG. "NK4 reduced the growth of prostate cancer in vivo".
Certificate of Merit at the American Society of Tissue Regeneration Conference, April 2001 for Martin TA, Jiang WG, and Harding KG. Effect of human fibroblast derived dermis on human tissue expansion. American Society of Tissue Regeneration Conference.
Professional memberships
- American Association of Cancer Research (AACR)
- Women in Cancer Research (WICR)
- British Association of Cancer Research
- European Association of Cancer Research
Academic positions
2014-present –Group Leader, Cardiff-China Medical Research Collaborative
2003 to 2014 – Lecturer, Metastasis and Angiogenesis Research Group, Cardiff University
2000-2003 Research Fellow, Metastasis and Angiogenesis Research Group, Cardiff University
1997- 2000 Research Fellow, Wound Healing Research Unit, University Department of Surgery at University of Wales College of Medicine
1996 Research Assistant, University of Wales Cardiff
Committees and reviewing
2004-2024 HTRGC
2015-2020 DCAGE Health and Safety Team
2017-present DCG EDI Committee
Supervisions
Mutli-disciplinary post-graduate research supervision: PhD and MD
Current student/s:
- Henson Han Gao PhD (collaboration with Engineering, Prof Johannes Benedikt)
Recent Pharmacology, MSc and Intercalated projects (2024):
- Chelsea Stevens
- Princess Musah Braimoh
- Nikoletta Mouskoh
- Weiyi Hu
- Patrick Brown
Recent International Research Fellows:
- Sue Xiashan Cao
- Wenjing Gong
- Shawn Zhang
- Ling Xin
- Huishan Zhao
Current supervision
Past projects
Successful supervision of over 40 PhD, MPhil and MD projects.
Engagement
Current Engagement with:
- Career Confident
- In2Science
- Welcome Inspire
- Project Search
Previous Engagement:
- Go Wales
- Nuffield Studentships
Contact Details
[email protected]
+44 29206 87209
Henry Wellcome Building for Biomedical Research, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN
Neuadd Meirionnydd, Floor 4, Room Postgraduate Research Office, University Hospital of Wales, Heath Park, Cardiff, CF14 4YS
+44 29206 87209
Henry Wellcome Building for Biomedical Research, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN
Neuadd Meirionnydd, Floor 4, Room Postgraduate Research Office, University Hospital of Wales, Heath Park, Cardiff, CF14 4YS
Research themes
Specialisms
- Cancer screening, prevention and early diagnosis
- Cancer cell biology
- Metastatic disease
- Novel cancer treatments